Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(3.40)
# 967
Out of 4,969 analysts
21
Total ratings
64.71%
Success rate
2.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintains: Buy | $70 → $95 | $57.49 | +65.25% | 2 | Sep 2, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $50 | $23.84 | +109.73% | 3 | Sep 2, 2025 | |
| KYTX Kyverna Therapeutics | Maintains: Buy | $5 → $10 | $3.59 | +178.55% | 1 | Aug 29, 2025 | |
| CBIO Crescent Biopharma | Reiterates: Buy | $25 | $13.68 | +82.75% | 2 | Aug 27, 2025 | |
| TIL Instil Bio | Reiterates: Buy | $125 | $29.22 | +327.79% | 2 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Reiterates: Sell | $5 | $18.16 | -72.47% | 1 | Aug 25, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $12.53 | +139.43% | 1 | Aug 22, 2025 | |
| MGX Metagenomi | Reiterates: Buy | $7 | $1.82 | +284.62% | 1 | Aug 19, 2025 | |
| ZURA Zura Bio | Maintains: Neutral | $3 → $2 | $2.02 | -0.99% | 1 | Aug 19, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $15.95 | +182.13% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $9 | $4.79 | +87.89% | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $5 | $2.47 | +102.43% | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $4.70 | +197.87% | 1 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $22.21 | +305.31% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.15 | +247.83% | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $11.40 | +119.30% | 1 | Aug 8, 2025 |
Ionis Pharmaceuticals
Sep 2, 2025
Maintains: Buy
Price Target: $70 → $95
Current: $57.49
Upside: +65.25%
Summit Therapeutics
Sep 2, 2025
Reiterates: Buy
Price Target: $50
Current: $23.84
Upside: +109.73%
Kyverna Therapeutics
Aug 29, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $3.59
Upside: +178.55%
Crescent Biopharma
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $13.68
Upside: +82.75%
Instil Bio
Aug 27, 2025
Reiterates: Buy
Price Target: $125
Current: $29.22
Upside: +327.79%
Sarepta Therapeutics
Aug 25, 2025
Reiterates: Sell
Price Target: $5
Current: $18.16
Upside: -72.47%
Tyra Biosciences
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $12.53
Upside: +139.43%
Metagenomi
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.82
Upside: +284.62%
Zura Bio
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.02
Upside: -0.99%
Oruka Therapeutics
Aug 18, 2025
Reiterates: Buy
Price Target: $45
Current: $15.95
Upside: +182.13%
Aug 15, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $4.79
Upside: +87.89%
Aug 15, 2025
Maintains: Buy
Price Target: $3 → $5
Current: $2.47
Upside: +102.43%
Aug 14, 2025
Reiterates: Buy
Price Target: $14
Current: $4.70
Upside: +197.87%
Aug 13, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $22.21
Upside: +305.31%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.15
Upside: +247.83%
Aug 8, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $11.40
Upside: +119.30%